Journal of Pediatric Gastroenterology and Nutrition

Case Reports

Combined Restitutive Therapy for Treatment of Immunosuppressive Refractory Crohn Disease

Corresponding Author

Jason R. Goldsmith

School of Medicine, MD/PhD Program, University of North Carolina, Chapel Hill

Address correspondence and reprint requests to Jason Goldsmith, MD, MS, Institute for Children's Advanced Nutrition, and Gastroenterology, 2300 North Commerce Parkway, Suite 315, Weston, FL 33326 (e-mail: [email protected][email protected]www.icangastro.com).Search for more papers by this author

Maureen Kelly,

Maureen Kelly

Department of Pediatrics, Division of Gastroenterology, Hepatology, and Nutrition, University of North Carolina, Chapel Hill

Search for more papers by this author

Katherine B. Freeman,

Katherine B. Freeman

New Hanover Regional Medical Center, Wilmington, NC

Search for more papers by this author

Debora Duro,

Debora Duro

Department of Pediatrics, Division of Gastroenterology, Hepatology, and Nutrition, University of North Carolina, Chapel Hill

Search for more papers by this author

Jason R. Goldsmith,

Corresponding Author

Jason R. Goldsmith

School of Medicine, MD/PhD Program, University of North Carolina, Chapel Hill

Maureen Kelly,

Maureen Kelly

Department of Pediatrics, Division of Gastroenterology, Hepatology, and Nutrition, University of North Carolina, Chapel Hill

Search for more papers by this author

Katherine B. Freeman,

Katherine B. Freeman

New Hanover Regional Medical Center, Wilmington, NC

Search for more papers by this author

Debora Duro,

Debora Duro

Department of Pediatrics, Division of Gastroenterology, Hepatology, and Nutrition, University of North Carolina, Chapel Hill

Search for more papers by this author

First published: 01 April 2015

https://doi.org/10.1097/MPG.0000000000000191

Citations: 3

The authors received funding from NIH (F30DK085906-03 to J.R.G.). D.D. is a member of the speakers' bureau for Abbott Nutrition, and consults for Nutrishare, Inc. The other authors report no conflicts of interest.

Share a link

Email
Wechat
Bluesky

REFERENCES

1Sartor RB. Microbial influences in inflammatory bowel diseases. Gastroenterology 2008; 134: 577–594.
10.1053/j.gastro.2007.11.059
CAS PubMed Web of Science® Google Scholar
2Loftus EV Jr. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology 2004; 126: 1504–1517.
10.1053/j.gastro.2004.01.063
PubMed Web of Science® Google Scholar
3Pithadia AB. Jain S Treatment of inflammatory bowel disease (IBD). Pharmacol Rep 2011; 63: 629–642.
10.1016/S1734-1140(11)70575-8
CAS PubMed Web of Science® Google Scholar
4Kaser A. Blumberg RS Autophagy, microbial sensing, endoplasmic reticulum stress, and epithelial function in inflammatory bowel disease. Gastroenterology 2011; 140: 1738–1747.
10.1053/j.gastro.2011.02.048
CAS PubMed Web of Science® Google Scholar
5Korzenik JR, Dieckgraefe BK, Valentine JF, et al. Sargramostim for active Crohn's disease. N Engl J Med 2005; 352: 2193–2201.
10.1056/NEJMoa041109
CAS PubMed Web of Science® Google Scholar
6Kelsen JR, Rosh J, Heyman M, et al. Phase I trial of sargramostim in pediatric Crohn's disease. Inflamm Bowel Dis 2010; 16: 1203–1208.
10.1002/ibd.21204
PubMed Web of Science® Google Scholar
7Smith JP, Stock H, Bingaman S, et al. Low-dose naltrexone therapy improves active Crohn's disease. Am J Gastroenterol 2007; 102: 820–828.
10.1111/j.1572-0241.2007.01045.x
CAS PubMed Web of Science® Google Scholar
8Largent-Milnes TM, Guo W, Wang H-Y, et al. Oxycodone plus ultra-low-dose naltrexone attenuates neuropathic pain and associated [mu.]-opioid receptor-Gs coupling. J Pain 2008; 9: 700–713.
10.1016/j.jpain.2008.03.005
CAS PubMed Web of Science® Google Scholar
9Goldsmith JR, Perez-Chanona E, Yadav PN, et al. Intestinal epithelial cell-derived mu-opioid signaling protects against ischemia reperfusion injury through PI3K signaling. Am J Pathol 2013; 182: 776–785.
10.1016/j.ajpath.2012.11.021
CAS PubMed Web of Science® Google Scholar

Citing Literature

Volume60, Issue4

April 2015

Page e31-e34

Combined Restitutive Therapy for Treatment of Immunosuppressive Refractory Crohn Disease

REFERENCES

Citing Literature

References

Information

About Wiley Online Library

Help & Support

Opportunities

Connect with Wiley

Combined Restitutive Therapy for Treatment of Immunosuppressive Refractory Crohn Disease

REFERENCES

Citing Literature

References

Related

Information